Latest News & Features
Americas
Pharmaceutical companies Lundbeck and Takeda have sued generic drug producer Lupin for infringing a patent directed to anti-depressant medication Trintellix (vortioxetine hydrobromide). 23 May 2018
Big Pharma
The UK Intellectual Property Office has published several proposals, including some addressing barriers to growth for IP-rich companies, in response to received views of IP with regard to the government’s Industrial Strategy. 22 May 2018
Americas
The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products. 21 May 2018
Americas
The US Court of Appeals for the Federal Circuit has affirmed a patent victory for industrial gases company Praxair against pharmaceutical business Mallinckrodt. 21 May 2018
Americas
Novartis has acquired clinical-stage gene therapy company AveXis. 18 May 2018
Americas
Four US pharmacies have filed an antitrust lawsuit against Allergan over the drug company’s “unlawful scheme” to maintain its patent monopoly over dry-eye treatment Restasis (cyclosporine ophthalmic emulsion). 17 May 2018
Americas
Illumina and Sequenom have filed a patent infringement case against Ariosa Diagnostics for a patent covering DNA testing in pregnant women. 17 May 2018
Americas
US agriculture company Calyxt has announced it has resolved a licensing dispute over DNA-editing technology with Bayer CropScience. 17 May 2018
Big Pharma
UK-based law firm DLA Piper has announced that it will open a new office in Dublin, Ireland in light of Brexit. 16 May 2018
Americas
Addiction drug producer Indivior has settled its patent infringement dispute with generics manufacturer Par Pharmaceutical. 16 May 2018